Allergan, Inc. v. Merz Pharmaceuticals: Central District of California Hammers Merz for Failure to Timely Produce Documents and Misappropriation of Trade Secrets and Halts Rollout of Xeomin for Ten Months
Continue Reading Allergan, Inc. v. Merz Pharmaceuticals: Central District of California Hammers Merz for Failure to Timely Produce Documents and Misappropriation of Trade Secrets and Halts Rollout of Xeomin for Ten Months

Thursday Wrap Up (March 8, 2012): Noteworthy Trade Secret, Non-Compete and Cybersecurity Stories from Around the Web
Continue Reading Thursday Wrap Up (March 8, 2012): Noteworthy Trade Secret, Non-Compete and Cybersecurity Stories from Around the Web

General Patent Corp. v. Wi-LAN, Inc.: To What Extent Can In-House Counsel Be Restrained from Working for Competitors?
Continue Reading General Patent Corp. v. Wi-LAN: To What Extent Can In-House Counsel Be Restrained from Working for Competitors?

Thursday Wrap-Up (Feb. 9, 2012): Noteworthy Trade Secret, Non-Compete and Cybersecurity from the Web
Continue Reading Thursday Wrap-Up (Feb. 9, 2012): Noteworthy Trade Secret, Non-Compete and Cybersecurity Stories from the Web

Thursday Wrap-Up (Feb. 2, 2012): Noteworthy Stories on Trade Secrets, Non-Competes and Cybersecurity on the Web
Continue Reading Thursday Wrap-Up (Feb. 2, 2012): Noteworthy Stories on Trade Secrets, Non-Competes and Cybersecurity on the Web

Second Circuit Affirms Holding That Employee’s Good Behavior Can Trump Non-Compete
Continue Reading IBM v. Visentin: Second Circuit Affirms Holding That Employee’s Good Behavior Can Trump Non-Compete

A recent federal case in California illustrates the challenges of proving irreparable injury in a trade secret dispute
Continue Reading Amylin v. Eli Lilly: Raising the Bar to Proving Irreparable Injury in the Trade Secret Case?